LAWRENCE, Kan.--(BUSINESS WIRE)--Dec 7, 2022--
Endpoints News announced today its annual Women in Biopharma special report, featuring 20 of the most extraordinary women engaged in drug research and development worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221207005142/en/
Endpoints News has honored 60 women over the past three years who’ve made lasting impacts in the drug development field — and this year’s group is no exception. Join us as we celebrate another 20 leaders who are making waves in R&D and blazing paths for others to follow. For the third time, we’re bringing the celebration to a live virtual audience.
Winners will be recognized today at a live virtual event hosted by Endpoints editors Amber Tong and Nicole DeFeudis at 2 PM ET. Registration is open at https://womeninbio22.endpts.com/.
The 2022 Women in Biopharma winners are:
"Though women account for roughly half of all employees in the biopharma industry, according to a recent BIO report, they occupy few executive and C-suite roles, especially in R&D. We invite you to join us and celebrate and honor the women who are changing that narrative, and our panel discussion on how the industry can do better," said Amber Tong, senior editor, Endpoints News.
A panel discussion moderated by Amber and Nicole titled: “From bench to boardroom, how can we empower more women to take charge?” will follow the virtual awards ceremony, featuring Jodie Morrison, Venture partner / Acting CEO, Atlas Ventures; Diem Nguyen, CEO, Xalud Therapeutics; Michelle Werner, CEO / CEO-Partner, Alltrna / Flagship Pioneering and Yesmean Wahdan, VP of US Medical Affairs in Women's Healthcare, Bayer Pharmaceuticals. Women in Biopharma 2022 is sponsored by Forge Biologics and Precision ADVANCE.
"Despite the incredible work our honorees have done to break the glass ceiling in biopharma R&D, there’s still much more to do. Women continue to be underrepresented in the upper ranks of the biopharma field. I'd like to thank our sponsors Forge Biologics and Precision ADVANCE for their support of our independent journalism and promoting diversity, equity and inclusion," said Arsalan Arif, Endpoints News founder and publisher. View the report here.
Endpoints News journalists selected the winners and conducted interviews throughout the year, culminating in today's live event and written report. All biopharma industry professionals have access to Women in Biopharma with a basic Endpoints News subscription, which is complimentary.
About Endpoints News
Endpoints News is biopharma’s trusted news authority, widely read at thousands of innovative biotechs and every top-50 pharmaceutical in the world. With a fully-remote workforce, Endpoints publishes three daily news reports, produces multiple industry-leading events and builds products that connect and inform sophisticated business audiences. Its in-house marketing agency Endpoints Studio works with over 140 advertisers to deliver data-driven campaigns across the Endpoints platform. For more information, visit endpts.com. Follow us on Twitter @endpts and on LinkedIn.
View source version on businesswire.com:https://www.businesswire.com/news/home/20221207005142/en/
KEYWORD: UNITED STATES NORTH AMERICA KANSAS
INDUSTRY KEYWORD: WOMEN BIOTECHNOLOGY PHARMACEUTICAL PUBLISHING HEALTH MEDIA COMMUNICATIONS CONSUMER
SOURCE: Endpoints News
Copyright Business Wire 2022.
PUB: 12/07/2022 07:00 AM/DISC: 12/07/2022 07:02 AM
No comments on this item Please log in to comment by clicking here